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Abstract.  Thrombin,  a potent activator of cellular re- 
sponses, proteolytically cleaves, and thereby activates 
its receptor.  In the present study, we compared the 
effects of the thrombin receptor  14-amino acid peptide 
(TRP-14; SFLLRNPNDKYEPF), which comprises the 
NH2 terminus after cleavage of the thrombin receptor, 
and of the native ot-thrombin on endothelial monolayer 
permeability.  Addition of TRP-14 (1-200 #M) to bo- 
vine pulmonary artery endothelial cells increased 
[Ca2+]i in a dose-dependent manner.  The peak increase 
in [Ca2+]i in response to  100 #M TRP-14 or 0.1  #M 
ot-thrombin was similar (i.e.,  931  +  74 nM and 
1032 +  80 nM,  respectively), which was followed by 
a  slow decrease with tirE values of 0.73 and 0.61 min, 
respectively. Extracellular Ca  z+ chelation with 5 mM 
EGTA abolished the sustained increases in [Ca~+]i in- 
duced by either TRP-14 or ol-thrombin,  ot-thrombin 
(0.1 /zM) increased transendothelial  [~25I]albumin per- 
meability, whereas TRP-14 (1-100 #M) had no effect. 
Coincubation of 100 #M TRP-14 with  1 #M DIP-a- 
thrombin also did not increase permeability over con- 
trol values.  Stimulation of BPAEC with 0.1 /~M 
ot-thrombin induced translocation of protein kinase C 
(PKC) from the cytosol to the plasma membrane in- 
dicative of PKC activation,  whereas TRP-14 had no 
effect at any concentration.  TRP-14 at  100 #M desen- 
sitized BPAEC to thrombin-induced increases in 
[Ca2+]i and transendothelial permeability.  The Ca  2+ 
desensitization was reversed after ,x,60 min,  and this 
recovery paralleled the recovery of the permeability 
response.  These findings indicate that the TRP-14- 
induced Ca  2+ mobilization in the absence of PKC acti- 
vation is insufficient to increase endothelial permeabil- 
ity. In contrast, the increase in endothelial permeability 
after ot-thrombin occurred in conjunction with Ca  2§ 
mobilization as well as PKC activation.  TRP-14 
pretreatment prevented the ot-thrombin-induced in- 
crease in endothelial permeability secondary to desen- 
sitization of the Ca  2+ signal.  The results suggest that 
combined cytosolic Ca  2§ mobilization mediated by 
TRP-14 and PKC activation mediated by a TRP-14- 
independent pathway are dual signals responsible for 
the thrombin-induced increase in vascular endothelial 
permeability. 
T  rIE procoagulant serine proteinase,  a-thrombin,  has 
a central  bioregulatory role in hemostasis and func- 
tions  as an agonist for diverse cellular activities  in- 
cluding  mitogenesis,  prostaglandin  synthesis,  chemotaxis, 
and smooth muscle contraction (9). Additionally,  t~-throm- 
bin can stimulate endothelial  cells leading to increased vas- 
cular endothelial  permeability and tissue edema (1,  12,  17, 
21, 22). These responses require activation  of thrombin re- 
ceptor(s) on the endothelial  cell and involve thrombin's pro- 
teolytic activity (1,  17). 
The  signaling  pathways  mediating  the  increase  in  en- 
dothelial permeability after thrombin receptor activation are 
poorly understood. Several lines of evidence suggest that the 
response is linked  to a  receptor-activated  cascade of sec- 
ond messengers  initiated  by activation  of phospholipase C 
(PLC) 1. ot-thrombin stimulates  endothelial  PLC, triggering 
the  generation  of inositol  1,4,5-trisphosphate  [Ins(1,4,5)- 
P3] from the hydrolysis of phosphatidylinositol  4,5-bisphos- 
phate (5,  18, 20), which in turn increases [Ca2+]i (cytosolic 
Ca  2§ concentration)  (5,  13,  18, 21, 22, 28), as well as the 
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C  (PKC) (5, 23). We have reported that ot-thrombin-medi- 
ated increase in endothelial permeability can be prevented by 
inhibition of PKC  activation (23).  An increase  in  [Ca2+]i 
may also be involved in the response (21) because the throm- 
bin-induced generation of Ins(1,4,5)P3  and the increase in 
[Ca2+]~ preceded  the  increase  in transendothelial albumin 
permeability (22). 
The deduced sequence determined from cloning of human 
(36)  and hamster (27)  thrombin receptors has indicated a 
novel mechanism of activation based on thrombin's proteo- 
lytic activity. The thrombin receptor is coupled to GTP- 
binding proteins and has seven hydrophobic segments span- 
ning the lipid bilayer (27, 36).  The thrombin receptor is 
unique in that the long extracellular extension (',~75 amino 
acids) is the substrate target containing the proposed cleav- 
age site (between R  4t and S  42) sensitive to thrombin's proteo- 
lytic activity. The remaining shortened extracellular portion 
after cleavage contains a newly exposed NH2 terminus that 
binds to as yet an undefined region on the thrombin receptor, 
and functions as a "tethered ligand" to activate the receptor 
(27, 36).  Synthetic peptides corresponding to the exposed 
NH2 terminus (i.e., SFLLRNPNDKYEPF) (TRP-14) elicit 
cellular responses  characteristic of native thrombin (e.g., 
platelet aggregation [15, 29, 36], increase in [Ca2+]~ in endo- 
thelial cells [26],  activation of PLC [15, 35], and activation 
of neutrophil adhesion via P-selectin expression on endothe- 
lial cells [31]). 
The issue has been raised whether all of thrombin's re- 
sponses are mediated by TRP-14,  which corresponds to the 
ot-thrombin-generated NH2  terminus of the  receptor  (29, 
31,  35).  The synthetic thrombin-receptor peptide induces 
PLC activation and serotonin release, but does not mediate 
proliferation of fibroblasts (35). In another study, the peptide 
desensitized the high affinity  thrombin receptors activated by 
low concentrations of oz-thrombin (<2 nM), but did not affect 
the responses mediated by higher thrombin concentrations 
(29).  Furthermore,  TRP-14  induced P-selectin expression 
and PMN adhesion to endothelial cells, whereas o~-thrombin 
mediated the additional expression of Intercellular Adhesion 
Molecule-1 (ICAM-1) and ICAM-l-induced PMN adhesion 
(31). The present study demonstrates that TRP-14 increases 
[Ca2+]i in endothelial cells as is the case with a-thrombin. 
In contrast to a-thrombin, TRP-14 did not increase transen- 
dothelial permeability, and moreover, did not activate PKC. 
Prior exposure of cells with TRP-14  produced a  transient 
desensitization of thrombin-induced [Ca2+]~ signal and pre- 
vented the increase in endothelial permeability. The results 
indicate  that  cytosolic  Ca  2+  mobilization  is  mediated  by 
TRP-14,  whereas  PKC  activation  occurs  by  a  TRP-14- 
independent mechanism.  Both Ca  2§ mobilization and PKC 
activation  are,  however,  required  to  signal  the  thrombin- 
induced increase in endothelial permeability. 
Materials and Methods 
Materials 
The  following materials  were  used:  Helms,  TCA,  BSA  (Fraction  V), 
bradykinin,  EGTA,  ionomycin (Sigma Chemical Co.,  St.  Louis,  MO); 
DME,  I-IBSS, PBS,  (Gibco Laboratories,  Grand Island,  NY);  polycar- 
bonate micropore filters (Nucleopore, Pleasanton, CA); 125I (New England 
Nuclear, Boston, MA); fura2/AM (acetoxymethyl ester) (Molecular Probes, 
Inc., Eugene, OR). 
Human a-thrombin and diisopropyl-fluorophosphate (DIP)-ct-thrombin 
were prepared as described (10, 11). Human ct-thrombin contained 98% 
~x-thrombin (with residual amounts of/~- and 3,-thrombin), and a specific 
clotting activity of 3345 U/mg protein and ,x,100% enzymatic activity as 
determined by active-site titration with p-nitrophenyl-p'  guanidino-benzoate 
(NPGB).  The DIP-a-thrombin had <1%  clotting activity of the starting 
a-thrombin, and was 8% active with the NPGB assay. 
Synthesis of Thrombin Receptor Peptide 
The peptide TRP-14 (SFLLRNPNDKYEPF) was synthesized  on a Bioseareh 
9500 automated peptide synthesizer employing the tBOC strategy (25) and 
assembled on methylbenzhydrylamine resin, yielding the COOH-terminal 
amide after removal from the resin. Hydrofluoric acid cleavage utilized the 
"low-high" method of Tam et al. (32), and was followed by purification of 
Sep-Pak cartridges (Millipore, Bedford, MA) and HPLC (reverse phase on 
a  Cts column utilizing a gradient of 0-60%  acetonitrile, 0.1% trifluoro- 
acetic acid). The purified lmptide subjected to amino acid analysis (2) yielded 
the desired composition. All concentrations were obtained from amino acid 
analysis data. The correct sequence was confirmed by automated gas phase 
sequencing on a Proton 2090E sequencer. 
We also studied the effects of a control acetylated TRP-14.  The TRP-14 
dissolved in water was reacted with an equal volume of acetic anhydride for 
1 hr at room temperature, and recovered by lyophilization. The acetylated 
TRP-14 was unreactive in a ninhydrin-based test for free amino groups in- 
dicative of acetylation of the NH2 terminus (19). 
Endothelial Cell Culture 
Bovine pulmonary artery endothelial cells (BPAEC) (cell line CCL-209) were 
obtained at the 16th passage from the American Type Culture Collection 
(Rockville, MD). These cells were characterized as endothelial ceils by the 
presence of angiotensin-converting enzyme activity, factor VIII-related an- 
tigen, and uptake of acetylated low density lipoprotein (8). 
Transendothelial  p2~I]Albumin Permeability 
The transendothelial [125I]albumin clearance rates in cultured monolayers 
of  BPAEC were measured using an in vitro system developed for assessment 
of endothelial permeability to proteins (7). This system measures the diffusive 
flux of  the tracer molecule across cell monolayers in the absence of  hydrostatic 
and oncotic pressure gradients. The system consisted of luminal and ablu- 
minal compartments separated by a polycarbonate microporous filter (0.8 
/zm pore diam). BPAEC were seeded at 10  s cells/filter and grown for 3 to 
4 d to attain confluency. Both compartments contained the same medium 
(DME, 20 mM Helms, 0.5 g% BSA, pH 7.4) at volumes of 700/~1 and 25 
ml, respectively.  The luminal compartment was fitted with a styrofoam outer 
ring, and floated in the abluminal medium so that fluid levels remained equal 
after repeated samplings from the abluminal compartment. The abluminal 
compartment was stirred continuously for rapid mixing and the entire sys- 
tem was kept at 37~  by a thermostatically-regulated water bath. 
Crystallized and lyophilized fatty acid-free BSA was purified by gel chro- 
matography and labeled with 125I using the chloramine-T procedure (4). 
Noncovalently bound 1251 was removed by dialysis against 0.1  M  NaI in 
PBS (pH 7.4).  Transendothelial clearance of [125i]albumi  n was determined 
as the volume of luminal chamber radioactivity cleared into the abluminal 
chamber. The change in volume over time provided the clearance rate in 
#l/rain  as  determined  by  weighted  least-squares  nonlinear  regression 
(BMDP Statistical Software, Berkeley,  CA). 
At  the  beginning of the  experiment,  the  luminal  compartment was 
"floated" in the abluminal medium, and filled with medium containing '~6 
/zCi/mi [125I]albumin.  Abluminal samples of 400  /zl of tracer were ob- 
tained at 5  rain intervals for 60 min, and counted for radioactivity in a 
gamma counter (Packard Instrument Co., Downers Grove, IL). At termina- 
tion of the experiment, the percent free ~25I in luminal and abluminal com- 
partments  was determined using  12%  TCA  precipitation.  The  luminal 
medium contained 1-2% free 125I. The transendothelial 125I-albumin clear- 
ance rates were corrected for the free t25I. 
Cytosolic Ca  2+ Determination 
Cytosolic [Ca  2+] was determined as reported (13, 21, 22). Briefly, BPAEC 
were seeded on 25-ram diam glass coverslips at 5  x  l0 t cells/coverslip, 
and  grown to  confluency (3-4  d).  The  cells were  loaded  with 5  #M 
fura2/AM for 60 min at room temlmrature, washed 3 ￿  with HBSS, and 
placed in a  Sykes-Moore chamber (Bellco, Vineland, N J). The chamber 
was placed onto the stage of an inverted Nikon Diaphot microscope which 
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fluorometer system (PTI, Inc., Princeton, NJ). An optically isolated group 
of 3--4 ceils was illuminated by a 75W xenon arc lamp at alternating excita- 
tion wavelengths of 340 and 380 ran. The emitted light was passed through 
an interference filter at 510 nm and collected via a photomultiplier. Fluores- 
cence intensity was measured at 10 points/s. Background autofluorescence 
(in the absence of fma2) was determined at beginning of each day's experi- 
ments, and was subtracted automatically during data collection. At the end 
of each experiment, 10 #M ionomycin was added to obtain fluorescence of 
Ca2+-saturated  fura2,  and 0.1  M  EGTA to obtain fluorescence of free 
fura2. The fluorescence ratio of excitation wavelengths 340 and 380 nm 
(340/380)  and [Ca2+]i were computed using the PTI software. The [Ca2+]i 
was calculated based on a K~ of 224 nM (14). 
Immunocytocheraical Protein Kinase C Localization 
Endothelial cell monolayers grown on coverslips (1  ￿  105 cellslcoverslip) 
were preincubated with either buffer alone or challenged with TRP-14 or 
a-thrombin. The monolayers were then fixed with 1% paraformaldehyde 
and processed for immunocytochemistry of protein kinase C using mono- 
clonal antibodies (Amersham Corp., Arlington Heights, IL) as described 
(16).  Fluorescein isothiocyanate fluorescence was examined using a Zeiss 
universal microscope equipped with x63 objective (numerical aperture 1.4, 
Carl Zeiss, Inc., Thornwood, NY). Images were obtained with a SIT cam- 
era (Hamamatsu Corp., Bridgewater, N J), and processed using a Tracor 
Northern 8500 image processor (Tracor Inc., Austin, TX). Photographs 
were taken from the monitor screen using TMAX 400 ASA Kodak film. 
usI-~-Thrombin Binding 
Alpha-thrombin was labeled by the chloramine-T procedure (4), and the la- 
beled reagent was  separated from excess 125I by chromatography on a 
Sephadex G-25 column. The t25I c~-thrombin had specific activity of 2.4 
#Ci/#g.  All binding experiments were made at 4~  with HBSS buffered 
with 20 mM Hepes/Tris (pH Z4).  Binding of 12sI-et-thrombin  was per- 
formed in a total buffer volume of 0.5 ml using 10 nM l:sI-a-thrombin and 
BSA (1 mg/ml). The BPAEC monolayers were washed 2 x  with the buffer 
before incubation. The binding was terminated by washing the BPAEC rap- 
idly 3 ￿  with buffer, and the cells were incubated with 0.6 ml of  0.3 N NaOH 
for 60 rain. The solubilized contents were transferred to counting vials and 
the radioactivity was counted. Nonspecific binding was determined by add- 
ing  100-fold  excess  of  unlabeled  ct-thrombin  during  the  incubation; 
nonspecific binding for z25I-a-thrombin  varied between 25 and 30%. 
Data Analysis 
Single sample data were analyzed by the two-tail t test. A multiple range 
test (Scheffe's test) was used for comparisons of experimental groups with 
a single control group (30). 
Results 
TRP-14 and ~-Thrombin Mobilize Cytosolic Ca  2+ and 
Differentially Activate Protein Kinase C 
TRP-14  (0.1,  1,  10,  100, and 200  #M)  added to BPAEC 
caused  concentration-dependent  increases  in  the  [Ca2+]~ 
(Table  I).  At  I0 and  100  /~M  TRP-14,  [Ca2+]~ increased 
7- and 15-fold over basal levels, respectively; whereas <1/~M 
TRP-14 produced no effect (Table I). The 200-/~M concen- 
tration of TRP-14  caused an increase in [Ca2+]i similar in 
magnitude to 100 #M TRP-14 (Table I). At 100/~M TRP-14, 
the 15-fold increase in [Ca2§  was similar in magnitude to 
that induced by 0.1/~M a-thrombin (a concentration shown 
to increase endothelial permeability by two to threefold). 
The t,~ values (time at which the peak response decreased 
50% of maximum value) were determined to assess the de- 
cay of the Ca  2+ responses. Both TRP-14-  and a-thrombin- 
induced increases in [Ca2+]~ showed similar decay constants 
with t~ values of 0.73 min and 0.61 rain, respectively (Table 
I).  In medium containing 5 mM EGTA, the peak rise in 
[Ca2+]j after 100 ttM TRP-14 (Fig. 1) or 0.1/zM c~-thrombin 
Table L [CaZ+]i Responses in Bovine Pulmonary 
Artery Endothelial Cells 
Basal  Peak 
Agonist  Concentration  [Ca2+]i  [Ca2+]i  tl/2*  * 
#M  nM  nM  min  n 
TRP-14  1  136  +  40  147  +  35  -  3 
10  98  +  9  677:1:73  1.1  +  0.2  6 
100  85  +  10  931  +  74  0.7  +  0.1  12 
200  74  +  11  984-t-  142  0.8  +  0.4  3 
AcTRP-14~  100  90  5:4  118  +  30  -  3 
c~-Thrombin  0.1  90  +  19  1032  +  80  0.6  +  0.1  7 
Values are shown as mean +  SEM. 
* Time at which the peak response decayed 50%  from maximum value. 
r Number of endothelial  monolayers. 
w Acetylated TRP-14  (a control peptide). 
-  indicates not done. 
stimulation (Fig. 1, inset) decreased to basal levels with the 
same time course. However,  EGTA did not alter the initial 
rise in [Ca2+]~ after either TRP-14  (Fig.  1) or ot-thrombin 
challenge (Fig.  1, inset), indicating that the initial response 
in both cases was the result of intracellular Ca  2§ mobiliza- 
tion.  A  control  TRP-14  peptide  with  the  NH2  terminus 
acetylated did not increase [Ca2+]i (Table I). 
Fig.  2  shows  the  immunocytochemical localization of 
PKC.  In  quiescent  (control)  cells,  PKC  was  distributed 
homogeneously within the cytosol (Fig. 2  c).  a-thrombin 
caused the translocation of PKC from the cytosol to plasma 
membrane indicative of  enzyme activation (Fig. 2 b). In con- 
trast, TRP-14 (as high as 200/zM concentration) incubated 
with BPAEC did not alter the PKC distribution (Fig. 2 a). 
TRP-14 and a-Thrombin Mediate Different Effects 
on Endothelial Permeability 
Addition of TRP-14 (1, 10, and 100 #M) or acetylated TRP- 
14 (100 #M) did not increase the transendothelial albumin 
permeability (Fig. 3). In contrast, ct-thrombin (0.1 /zM) in- 
creased the permeability by ~200% over the control value 
(Fig.  3).  We coincubated endothelial cells with  100  #M 
TRP-14 and 1 #M DIP-a-thrombin (which lacks enzymatic 
activity but retains its high affinity binding capability [11]) 
to  determine whether TRP-14  required the  simultaneous 
binding of thrombin to its receptor to mediate the permeabil- 
ity response. The results indicated that the combination of 
TRP-14 and DIP-a-thrombin also did not increase transen- 
dothelial [12q]albumin permeability (Fig. 4). 
Receptor Desensitization Mediated 
by TRP-14 Prevents ct-Thrombin-Induced Increase 
in Endothelial Permeability 
BPAEC preloaded with fura2 were stimulated with 100 #M 
TRP-14, and changes in [Ca2§  were monitored to study the 
time  course  of desensitization.  When  the  response  had 
decayed to a new steady-state (i.e.,  "-,3 min after TRP-14 
stimulation), the cells were restimulated with either 100/~M 
TRP-14 or 0.1/~M thrombin. The initial stimulation with 100 
#M  TRP-14  caused  the  characteristic  increase  in  [Ca2+]~ 
from 77  +  10 to 984  +  75 nM after which the response 
slowly decreased to a new steady-state value by •3  min (Fig. 
5 a). The second challenge with 100 #M TRP-14 or 0.1/~M 
ot-thrombin at this point failed to increase [Ca2§  (Fig. 5 a). 
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Figure L  Effects of 100/~M 
TRP-14 and 0.1 #M o~-throm- 
bin (tx-Thr)  (inset) on changes 
in  the  [Ca2+]i in  BPAEC in 
the  presence  or  absence  of 
chelation of Ca  2§ with 5 mM 
EGTA (EGTA added before 
stimulation with  agonists as 
described in Methods). Time 
point of agonist stimulation is 
indicated by short arrow. Rep- 
resentative tracings are from 
three separate experiments. 
However, when BPAEC were initially stimulated by 100/xM 
acetylated TRP-14,  the  second challenge with  TRP-14 or 
c~-thrombin,  produced the typical increase in [Ca2§  indi- 
cating that acetylated TRP-14 did not desensitize the cells 
(Fig. 5 a, inset). The ceils were also fully responsive to 0.1 
#M bradykinin when BPAEC were initially stimulated with 
100/,M TRP-14 (Fig. 5 b). 
The effects of TRP-14-induced desensitization on the en- 
dothelial permeability response were studied using BPAEC 
grown on microporous filters. The cells were stimulated with 
TRP-14 for 5 min, washed, then restimulated with 0.1 #M 
tx-thrombin, and endothelial permeability was determined. 
Preexposure of BPAEC with 100/~M TRP-14 (but not with 
10/zM TRP-14) prevented the ct-thrombin-induced increase 
in  endothelial  [~25I]albumin permeability,  whereas  preex- 
posure with 100/~M TRP-14 did not affect the permeability 
increase in response to bradykinin (Fig. 6). 
In a  separate series of experiments, we determined the 
time required for BPAEC to recover from desensitization in- 
duced by TRP-14. Cells were initially stimulated with 100 
/~M TRP-14 for 5 min, washed, reincubated in fresh medium 
for 10, 30, or 60 min, at which time they were restimulated 
with 0.1  #M a-thrombin, and the increases in [Ca2+]i and 
transendothelial [~z~I]albumin permeability were monitored 
(Fig. 7, a and b). BPAEC were refractory  to ct-thrombin after 
incubation in fresh medium for 10 min and the response was 
of the level observed in control. However, at 30 min the rise 
in [Ca2§  in response to oL-thrombin was "'43% of the re- 
sponse in control thrombin-exposed cells (Fig. 7 a). Alpha- 
thrombin did not cause increases in endothelial permeability 
at either 10 or 30 min after the initial stimulation with TRP- 
14 (Fig. 7 b). However, the cells recovered completely by 60 
min after TRP-14 stimulation; that is, the magnitude of the 
ct-thrombin-induced  increases  in  [Ca2§  and  endothelial 
permeability were >90%  of the control cells at this time 
(Fig. 7, a  and b). 
We determined the effects of initial stimulation with TRP- 
14 on c~-thrombin binding to BPAEC because the response 
to TRP-14-induced desensitization may be explained by de- 
creased binding of ot-thrombin to its receptor. BPAEC were 
pretreated with  100/~M TRP-14 for 5 min,  washed,  rein- 
cubated in fresh medium for 10, 30, or 60 min, and the bind- 
ing  of ~25I-tx-thrombin was  determined.  The results  indi- 
cated that 100/zM TRP-14 did not decrease ~25I-o~-thrombin 
binding to BPAEC as compared to leSI-ot-thrombin binding 
to control cells (Table II). 
Discussion 
The present study demonstrates that (a) TRP-14 is as compe- 
tent  an  agonist  as  a-thrombin  in  increasing  [Ca2§  in 
BPAEC, but in contrast to tx-thrombin it does not activate 
PKC and it does not increase endothelial monolayer perme- 
ability to albumin; (b) TRP-14 desensitizes BPAEC to the in- 
creases in [Ca2+]i and endothelial permeability mediated by 
tx-thrombin;  and  (c)  recovery  from  the  TRP-14-induced 
desensitization of the Ca  2§ response parallels the restora- 
tion of the endothelial permeability response. 
We observed that TRP-14 at 100/~M elicited an increase 
in [Ca2+]i of the same magnitude as observed with 0.1 /zM 
tx-thrombin. Vu et al. (36) have also observed that a 100-fold 
greater TRP-14 than ot-thrombin concentration was required 
The Journal of Cell Biology,  Volume 120, 1993  1494 ea  25- 
r162 
~  20 - 
"i  ~  K  is 
~  05- 
.  o l 
Control  o~Thr  1  lO  lOO  1oo 
t  TRP-I.  i  I  AcTRP-14 I 
(IJM)  ~---(pM) -~J 
Figure 3. Effects of 0.1 pM ct-thrombin (a-Thr) and 1 #M,  10 pM 
and  100 #M TRP-14 on the  transendothelial  clearance  rates of 
[1251]albumin. Numbers  of BPAEC monolayers were 46,  29,  30, 
36, and 37 for the control, t~-thrombin, 1 pM TRP-14, 10/~M TPR- 
14,  and  100  #M  TRP-14 groups,  respectively.  The  effects of 
acetylated TRP-14 (AcTRP-14)  (control TRP-14)  were determined in 
14 monolayers. Values are shown as mean +  SEM.  (*) Indicates 
significant differences compared to the control group (p <  0.01). 
for  maximal  'sCa~+ release  from  oocytes  expressing  the 
thrombin receptor. The higher TRP-14 requirement is likely 
related  to  its  lower  binding  affinity  (•2  #M)  to  the  en- 
dothelial plasma membrane compared to o~-thrombin bind- 
ing (33). Also, i>100 #M concentrations of TRP-14 approach 
the saturating level because a similar Ca  2+ response was ob- 
served at 100 and 200/~M TRP-14. 
TRP-14 and ot-thrombin both produced rapid increases in 
[Ca2§  followed by  slow  decay to  sustained  values  above 
baseline. Removal of extracellular Ca  2+ with EGTA in both 
cases abolished the  sustained phase of the Ca  2§ response. 
Thus, the transient initial rise in cytosolic Ca  2§ is attributed 
to mobilization of Ca  2§  from intracellular  stores,  and the 
Figure 2.  Immunoeytochemical  localization  of PKC in BPAEC 
monolayers (see Methods for details).  (A) BPAEC stimulated with 
200 #M TRP-14 for 30 min;  (B) BPAEC treated  with  0.1  pM 
t~-thrombin for 30 min; and (C) control cells. Arrowheads indicate 
immunofluorescence of  PKC translocated to the plasma membrane. 
Results  are  representative  of three  experiments.  Magnification, 
1,000. 
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Figure 4. Effects of  coincubation with 1 t~M DIP-t~-thrombin (DIP- 
c~-Thr) plus 100 #M TRP-14 on the transendothelial  [l~I]albumin 
clearance  rate.  Values are shown as mean  +  SEM  (n  =  6 per 
group). (*) Indicates significant differences compared to the control 
group (p < 0.01). 
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Figure 5. Representative  trac- 
ings  showing  the  effects  of 
sequential  stimulation  with 
agonists on the Ca  2+ response 
in  BPAEC.  Arrow  indicates 
the time point of agonist addi- 
tion. (a) BPAEC were initially 
challenged with 100 #M TRP- 
14 followed by a second chal- 
lenge  with  either  100  #M 
TRP-14  (n  =  4)  or 0.1  #M 
a-thrombin  (c~-Thr) (n  =  4) 
during the steady-state  condi- 
tion; BPAEC were stimulated 
with 100 #M acetylated  TRP- 
14 (AcTRP-14), then followed 
by either 100 #M TRP-14 (n = 
3) or 0.1 #m ct-Thr (n = 3) (in- 
set).  The tracings are off-set 
for clarity. (b) BPAEC initially 
'  stimulated with 100 #M TRP- 
14 (arrow) followed by a sec- 
ond  challenge  with  0.1  #M 
bradykinin (BK) (n  =  3). 
sustained phase can be attributed to influx of extracellular 
Ca  2§  Prior exposure of BPAEC with TRP-14 prevented the 
increase  in [Ca2+]+ upon stimulation with either TRP-14 or 
ct-thrombin.  The desensitization  of the Ca  2§ response sug- 
gests that ct-thrombin and TRP-14 are both capable of activat- 
ing the same receptor and signaling pathways that mediate 
the  increase  in  [Ca2+]i. This  would occur if the  synthetic 
TRP-14  functions  as  a  ligand  in  the  same  manner  as  the 
NH2  terminus  of the  receptor  after  the  cleavage  of the 
thrombin  receptor  (36).  The  present  results  indicate  that 
TRP-14 contains all of the essential  structural information 
needed to activate the Ca  2§ signal in endothelial  cells. 
The control acetylated TRP-14 neither  increased  [Ca2+]i 
and endothelial permeability nor desensitized the BPAEC to 
subsequent c~-thrombin challenge.  Because the NH2 termi- 
nus was acetylated,  the results  suggest that the first amino 
acid of TRP-14,  S 42, is required  to activate the endothelial 
thrombin receptor, and thereby to increase endothelial per- 
meability. The importance of the terminal amino acid is also 
supported  by  the  observation  that  the  inverted  TRP-14 
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Figure 6. Effects of combined TRP-14 and a-thrombin challenge on 
transendothelial  [|25I]albumin clearance  rate. BPAEC monolayers 
pretreated  with TRP-14 (10 or 100 #M) were stimulated with 0.1 
~M ct-thrombin (c~-  Thr), or 0.1/~M bradykinin (BK), and the trans- 
endothelial clearance rates of [125I]albumin were determined.  The 
number of monolayers for the groups ranged from 12 to 46. Values 
are shown as mean + SEM. (*) Indicate significant difference com- 
pared to the control  group (p < 0.01). 
~SLLRNPNDKYEPF) did not induce 4~Ca2+ release in oo- 
cytes expressing the thrombin receptor (36). 
Despite the ability of TRP-14 to increase [Ca2+]i, TRP-14 
did  not increase transendothelial  albumin permeability at 
concentrations as high as 100/~M that did increase [Ca2+]~. 
At ot-thrombin concentrations  which  raised  [Ca2+]i to the 
similar magnitude as 100 t~M TRP-14, the transendothelial 
[125I]albumin  permeability increased  ,'~ twofold.  Although 
the desensitization studies indicated that TRP-14 and c~-throm- 
bin  both  activated the  same  receptor,  it  appears that  the 
o~-thrombin-induced increase in endothelial permeability is 
mediated by pathways in addition to those solely activated by 
TRP-14. 
We have observed that 3,-thrombin, an enzymatically ac- 
tive c~-thrombin that does not compete for high-affinity bind- 
ing sites (10, 11), was less potent than o~-thrombin in increas- 
ing endothelial permeability (1). This suggests that binding 
of thrombin to high-affinity sites may play an obligatory role 
in mediating the thrombin-induced increase in permeability; 
therefore, it is possible that the inability of TRP-14 to in- 
crease endothelial permeability was related to a lack of oc- 
cupancy  of these  sites.  However,  the  addition  of DIP-c~- 
thrombin (which binds to high affinity thrombin receptors 
but is enzymaticaUy inactive [11]) and TRP-14 in an attempt 
to reconstitute the signal did not increase permeability, sug- 
gesting that occupancy of the thrombin receptor is not essen- 
tial for the permeability response. 
We observed that (x-thrombin shifted PKC activity from 
the cytosol to membrane indicative of PKC activation, which 
has also been noted previously (23). In contrast, TRP-14 did 
not translocate PKC to the plasma membrane. Because inhi- 
bition of PKC translocation was shown to prevent the in- 
crease in endothelial permeability in response to a-thrombin 
(23), we postulate that the lack of effect of TRP-14 in increas- 
ing endothelial permeability is somehow related to the in- 
ability of TRP-14 to activate PKC. The present study sup- 
ports the  critical  role of PKC  activation  in  signaling  the 
increase in endothelial permeability. 
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Figure 7. Time course of recovery from TRP-14-induced desensiti- 
zation  of (a)  Ca  2+  response  and  (b)  endothelial  permeability. 
BPAEC were stimulated with 100/zM TRP-14 for 5 min, incubated 
in fresh medium for either 10, 30, or 60 min, and then stimulated 
with 0.1 #M ~-thrombin.  Changes in [Ca2+]i and transendothelial 
[l:5I]albumin  clearance  rates  were  determined.  The  Ca  2+  re- 
sponses (in Fig. 7 a) are representative from three to four determi- 
nations per group. Short arrow indicates time point of  the ct-throm- 
bin (c~-Thr) addition;  long arrow indicates experimental  groups. 
The c~-Thr  group was not pretreated with 100 #M TRP-14. The per- 
meability responses to a-thrombin at 10, 30, and 60 min after TRP- 
14 preexposure are shown (in Fig. 7 b) along with the responses 
of control cells that were preexposed to DME for the same dura- 
tions.  The permeability  data are from 8 to 36  monolayers per 
group. The results are reported as mean + SEM. The control group 
(C) represents the basal permeability value of BPAEC monolayers. 
(*) Indicate  significant difference from the DMEM group at the 
same time point (p < 0.01); (I-) indicates significant difference from 
control  (p < 0.01). 
Accumulating evidence suggests that synthetic thrombin 
receptor peptides elicit some but not all of c~-thrombin's  ac- 
tions. Vouret-Craviari et al. (35) found that peptides corre- 
sponding to the cloned hamster thrombin receptor's tethered 
ligand activated PLC and serotonin release in hamster fibro- 
blasts, but did not induce mitogenesis as was the case with 
the native ct-thrombin, indicating differences in ct-thrombin 
and TRP-14-mediated responses.  Synthetic peptides corre- 
sponding to the tethered ligand of the cloned human throm- 
bin receptor induced the responses associated only with acti- 
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Binding to Bovine Pulmonary Artery Endothelial Cells 
~2Sl-~x-thrombin  bound 
(fmol/106 cells) 
Control  540.0  +  26.9  (7) 
10 min  518.2  +  26.6  (7) 
30 min  518.3  +  28.2  (7) 
60 min  506.8  +  20.9  (7) 
Values are shown as the mean +  SEM. 
Number in parenthesis indicate  number of monolayers studied. 
BPAEC were stimulated with t00 #M TRP-14 for 5 rain, washed 2x, rein- 
cubated in fresh HBSS for 10, 30, or 60 rain, and binding of ~25I-u-thrombin 
was determined (see Methods for details). The control cells were exposed to 
DME. 
vation of  high affinity  thrombin binding sites (29), suggesting 
that c~-thrombin and TRP-14  can activate different signal 
transduction pathways. The present results indicate that cel- 
lular responses mediated by TRP-14 and r  are dis- 
tinct. A possible explanation of our data is that ~x-thrombin's 
proteolytic activity causes a conformational change of the 
thrombin receptor that may be different from that mediated 
by the nonproteolytic TRP-14 (34, 36)such that different sig- 
naling pathways are activated.  Another possibility is that 
ot-thrombin can activate additional pathways (e.g., phospho- 
lipase D) which can prolong the generation of diacylglycerol 
needed for the activation of PKC (3), and thereby increasing 
endothelial permeability (23). 
Because TRP-14  resulted  in  the  desensitization of the 
thrombin receptor and also did not independently increase 
endothelial permeability, we used the approach of  desensitiz- 
ing the thrombin receptor with TRP-14 to determine throm- 
bin's effect on endothelial permeability. The results indicated 
that TRP-14  preexposure of BPAEC prevented the throm- 
bin-induced increase in endothelial permeability. However, 
this effect was short lived in that inhibition was evident at 
10-30  min after TRP-14  preexposure,  and recovery was 
complete by 60 min. The inhibitory effect of TRP-14 on per- 
meability was temporally related to the refractory period of 
the Ca  2+ response, which supports an important facilitative 
role of Ca  2+ in the permeability response. The results are 
consistent with the hypothesis that PKC activation signals the 
increase in endothelial permeability (23) because cells that 
are unable to mobilize intracellular Ca  2+ may have an im- 
paired PKC activation response (24). 
Previous studies have suggested that the thrombin-induced 
increase in [Ca2+]i is an important initial event mediating 
the increase in endothelial permeability (21, 22). The pres- 
ent results also point to the rise in [Ca2+]i as a critical first 
step required for the thrombin-induced increase in perme- 
ability. The inhibition of  the permeability response likely oc- 
curred at the receptor level since TRP-14 pretreatment did 
not interfere with bradyldnin-induced increases in  [Ca2+]i 
and endothelial permeability. Our results suggest that the in- 
hibitory effect of TRP-14  on the  ot-thrombin-induced in- 
crease in permeability is related to TRP-14-induced receptor 
activation, and to subsequent receptor desensitization, such 
that ~-thrombin is now unable to activate its receptor. 
TRP-14-induced  desensitization  is  likely  mediated  by 
events  downstream  from  the  ligand-receptor  level  since 
TRP-14 pretreatment did not interfere with binding of ~25I- 
ot-thrombin to BPAEC. Brass (6) recently showed in a leu- 
kemic cell line that the synthetic thrombin receptor peptide 
induces the desensitization of the Ca  2+ response by receptor 
phosphorylation because treatment with phosphatase inhibi- 
tors prolonged the refractory period.  This finding was in 
contrast to desensitization mediated by ot-thrombin because 
thrombin modified its receptor by proteolytic cleavage, and 
thus the refractory period persisted for up to ~,24 h (6). We 
found that the recovery time of BPAEC desensitized by TRP- 
14 pretreatment occurred within ~60 min, when the cells 
were fully responsive to ot-thrombin. The time course of the 
recovery  is  consistent with the proposed  receptor  phos- 
phorylation mechanism of desensitization (6). 
In summary, TRP-14 and tx-thrombin similarly increased 
[Ca2+]i in BPAEC; however, TRP-14 did not increase trans- 
endothelial albumin permeability and also did not activate 
PKC in contrast to the actions oftx-thrombin. In fact, TRP-14 
pretreatment prevented the o~-thrombin-induced increases in 
intracellular Ca  2+ and endothelial permeability secondary 
to TRP-14-induced  desensitization of the Ca  2§ signal. The 
results suggest that Ca  2+ mobilization and PKC activation 
are the dual signals required for the a-thrombin-induced in- 
crease  in  endothelial permeability.  Desensitization of the 
thrombin receptor by TRP-14 or related synthetic peptides 
may be a means of preventing tx-thrombin-induced increase 
in vascular endothelial permeability and mitigating the pro- 
inflammatory properties of thrombin. 
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